On June 26, 2020, Maheen Porter, then age 30, called her husband, Austin, into the bedroom of their Nashville-area home to join a phone call from a nurse practitioner at Vanderbilt-Ingram Cancer Center. Porter sat down on the floor for the call, which concerned results of her recent breast mass biopsy. The nurse informed the […]
When the first cancer patients in Tennessee underwent chimeric antigen receptor (CAR) T-cell therapy in 2015, they had to be hospitalized for two months and closely monitored for serious reactions. Those clinical trials by oncologists at Vanderbilt-Ingram Cancer Center and other academic centers nationwide led to the approval of the powerful new immunotherapy for patients […]
G. Lee Bryant Jr., MD, remembers when he first noticed something odd about his right thumb. In December 2016, a streak of redness appeared under his thumbnail, and splitting at the nail’s end never seemed to resolve. That concern – and the path it put him on – ultimately led Bryant to create a blog […]
Damaris Olagundoye, MD, grew up knowing that her maternal grandmother was a breast cancer survivor. She would listen as her mother talked with cousins who had also been diagnosed with the disease, but her family didn’t learn until decades later that they carried a mutation in the BRCA2 gene. Her mother’s heritage was Afro Panamanian, […]
Twenty years ago, Vanderbilt-Ingram Cancer Center (VICC) established the nation’s first Specialized Program of Research Excellence (SPORE) to focus exclusively on colorectal cancer, the second leading cancer killer after lung cancer. Directed by Robert J. Coffey, MD, and continuously funded by the National Cancer Institute (NCI) since 2002, the gastrointestinal (GI) SPORE has fostered a […]
Claudia Barajas recently put on headphones at El Jefe, a Nashville-based Hispanic radio station, to moderate an information-packed discussion about lung cancer prevention and the importance of screenings for individuals at higher risk of developing lung cancer. Her Spanish-speaking guest was Rafael Paez, MD, a clinical fellow in the Department of Medicine, Division of Allergy, […]
Charlotte Ladd’s work history has been a series of serendipitous opportunities ranging from investment banking to oncology nursing to teaching immigrant nurses in Florida. But it’s her work as a volunteer at Vanderbilt-Ingram Cancer Center that has brought her the greatest joy. Ladd volunteers on Tuesdays and Thursdays in the waiting room of the Henry-Joyce […]
Pietenpol named chief scientific and strategy officer Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center (VICC), Benjamin F. Byrd Jr. Professor of Oncology and Executive Vice President for Research for Vanderbilt University Medical Center, is stepping down on June 30 from her long-held role as the Cancer Center’s director to focus on a combined leadership […]
If Landon Ryan had been diagnosed with bilateral retinoblastoma 10, 20 or 30 years ago, she might not be here today with nearly perfect vision. Thanks to recent improvements in the treatment for this rare form of cancer that almost exclusively affects children under the age of 5, the diagnosis had the power to change […]
Vanderbilt-Ingram Cancer Center (VICC) has taken multiple measures since the COVID pandemic began two years ago to protect its patients, study how the disease affects immunocompromised people and provide them with an extra shield against infection. “The pandemic brought unique challenges and required quick changes in how we provided care,” said Laura Goff, MD, executive […]
